Join us to explore the role of Genetics as a way to bring Precision Medicine to the Brain! We will focus on opportunities and challenges of using “big data” from large healthcare systems, including genetics, to enhance the care of people with autism and other neuropsychiatric disorders.
David H. Ledbetter, PhD, FACMG. Executive Vice President & Chief Scientific Officer at Geisinger Health System. “Our ultimate goal is to help improve healthcare by finding ways to diagnose medical conditions earlier or before they appear and also find new treatments or medications to manage these diseases.”
Christa Lese Martin, PhD, FACMG. Director & Professor at Geisinger Health System. “Our aim is to promote data sharing among laboratories and clinicians to guide clinical interpretation of genomic variation–something that is becoming a part of medical practice every day.” The database will allow for shared knowledge, standardization and ultimately improved quality of patient care, with a strong focus on people with autism and other neurodevelopmental disorders.”
David Housman, PhD. Virginia & D.K. Ludwig Scholar for Cancer Research, & Professor of Biology at MIT Department of Biology. “Our laboratory uses genetic approaches to identify the mechanistic bases of human disease pathology to develop effective strategies for intervention in human disease. Our efforts are focused in three major disease areas: trinucleotide repeat disorders particularly Huntington’s disease (HD), cancer and cardiovascular disease.”